Journal of Hepatology
Volume 49, Issue 4 , Pages 537-547 , October 2008

Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains

  • Daniel Candotti

      Affiliations

    • National Health Service Blood and Transplant, Cambridge Blood Centre, Cambridge, United Kingdom
  • ,
  • Piotr Grabarczyk

      Affiliations

    • Institute of Haematology and Transfusion Medicine, Warsaw, Poland
  • ,
  • Paola Ghiazza

      Affiliations

    • Struttura di Qualificazione Biologica del Sangue, Ospedale Sant’ Anna, Torino, Italy
  • ,
  • Roberto Roig

      Affiliations

    • Centro Transfusion Comunidad Valencia, Valencia, Spain
  • ,
  • Natalia Casamitjana

      Affiliations

    • Centre de Transfusió i Banc de Teixits, Barcelona, Spain
  • ,
  • Paola Iudicone

      Affiliations

    • Azienda Ospedaleria S Camillo-Forlanini, Rome, Italy
  • ,
  • Michael Schmidt

      Affiliations

    • Institute of Transfusion Medicine and Immunohematology, Johann Wolfgang Goethe University, Frankfurt, Germany
  • ,
  • Arthur Bird

      Affiliations

    • Western Province Blood Transfusion Service, Cape Town, South Africa
  • ,
  • Robert Crookes

      Affiliations

    • South African National Blood Service, Johannesburg, South Africa
  • ,
  • Ewa Brojer

      Affiliations

    • Institute of Haematology and Transfusion Medicine, Warsaw, Poland
  • ,
  • Michelina Miceli

      Affiliations

    • Azienda Ospedaleria S Camillo-Forlanini, Rome, Italy
  • ,
  • Azin Amiri

      Affiliations

    • Department of Haematology, University of Cambridge, Cambridge Blood Centre, Long Road, Cambridge CB2 2PT, United Kingdom
  • ,
  • Chengyao Li

      Affiliations

    • National Health Service Blood and Transplant, Cambridge Blood Centre, Cambridge, United Kingdom
    • Southern Medical University, Guangzhou, China
  • ,
  • Jean-Pierre Allain

      Affiliations

    • Department of Haematology, University of Cambridge, Cambridge Blood Centre, Long Road, Cambridge CB2 2PT, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 1223 548044; fax: +44 1223 548155.

Received 6 February 2008 ,Revised 8 April 2008 ,Accepted 19 April 2008.

References 

  1. Allain J-P. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004;86:83–91
  2. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain J-P, Letowska M, et al. Characterization of HBV DNA+/HBsAg− blood donors in Poland identified by triplex NAT. Hepatology. 2006;44:1666–1674
  3. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996;2:1104–1108
  4. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007;46:160–170
  5. Allain J-P, Reesink HW, Lucey C. A European perspective on the management of donors and units testing positive for hepatitis B virus DNA. Transfusion. 2006;46:1256–1258
  6. Allain J-P. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening. Vox Sang. 2007;92:254–257
  7. Koppelman MH, Sjerps MC, Reesink HW, Cuypers HT. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection. Vox Sang. 2005;89:193–200
  8. Schmidt MC, Nubling M, Scheiblauer H, Chudy M, Walch LA, Seifried E, et al. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Vox Sang. 2006;91:237–243
  9. Sauleda S, Maymo RM, Piron M, Candotti D, Allain J-P, Hernandez JM, et al. Serological and molecular markers of hepatitis B virus in Spanish blood donors: evidence of occult hepatitis B. Vox Sang. 2006;93:63
  10. Heyns ADP, Swanevelder JP, Lelie PN, Crookes RL, Busch MP. The impact of individual donation NAT screening on blood safety. ISBT Science Series. Vox Sang. 2006;203–308
  11. Zahn A, Li C, Danso K, Candotti D, Owusu-Ofori S, Temple J, et al. Molecular characterization of occult hepatitis B in genotype E-infected subjects. J Gen Virol. 2008;89:409–418
  12. Candotti D, Opare-Sem O, Rezvan H, Sarkodie F, Allain J-P. Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine amino transferase. J Viral Hepat. 2006;13:715–724
  13. Abou-Jaoudé G, Sureau C. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of Delta virus. J Virol. 2005;79:10460–10466
  14. Dzierzanowska-Fangrat K, Woynarowski M, Szczygielska I, Jozwiak P, Cielecka-Kuszyk J, Dzierzanowska D, et al. Hepatitis B virus genotypes in children with chronic hepatitis B in Poland. Eur J Gastroenterol Hepatol. 2006;18:655–658
  15. Bielawski KP, Charmuszko U, Dybikowska A, Stalke P, Podhajska AJ. Genetic variability of hepatitis B virus isolates in Poland. Virus Genes. 2006;33:77–86
  16. Bielawski KP, Dybikowska A, Lisowska-Charmuszko U, Stalke P, Gregorowicz K, Trocha H, et al. Distribution of HBV genotypes and mutants among hepatitis B infected patients from northern Poland. Int J Mol Med. 2004;14:301–304
  17. Dal Molin G, Poli A, Croce LS, D’Agaro P, Biagi C, Comar M, et al. Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North-Eastern Italy. J Med Virol. 2006;78:734–740
  18. Medici MC, Aloisi A, Martinelli M, Abelli LA, Casula F, Valcavi P, et al. HBV genotypes and antiviral-resistant variants in HBV infected subjects in Northern Italy. New Microbiol. 2006;29:63–67
  19. Rodriguez-Frias F, Jardi R, Buti M, Schaper M, Hermosilla E, Valdes A, et al. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection. J Viral Hepat. 2006;13:343–350
  20. Avellon A, Echevarria JM. Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol. 2006;78:24–36
  21. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995;13:29–60
  22. Westover KM, Hughes AL. Evolution of cytotoxic T-lymphocyte epitopes in hepatitis B virus. Inf Gen Evol. 2007;7:254–262
  23. Scheiblauer H, Soboll H, Nick S. Evaluation of CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and Hepatitis B virus mutant detection. J Med Virol. 2006;78:S66–S70
  24. Hsu HY, Chang MH, Liaw SH, Ni YH, Cheng HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology. 1999;30:1312–1317
  25. Coleman PF, Chen YCJ, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol. 1999;24:19–24
  26. Jolivet-Reynaud C, Lesénéchal M, O’Donne B, Becquart L, Foussadier A, Forge F, et al. Localization of hepatitis B surface antigen epitopes present on variants and specifically recognized by anti-hepatitis B surface antigen monoclonal antibodies. J Med Virol. 2001;65:241–249
  27. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336:325–329
  28. Carman WF, Owsianka A, Wallace LA, Dow BC, Mutimer DJ. Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. J Hepatol. 1999;31:195–201
  29. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, et al. Cytotoxic T lymphocyte response to a wild-type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med. 1994;180:933–943
  30. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology. 2007;45:277–285
  31. Chaudhuri V, Tayal R, Nayak B, Kumar Acharya S, Kumar Panda S. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology. 2004;127:1356–1371
  32. Ghiazza GP, Cesale Ros E, Cornagliotto G, Demarin G, Demarchi G, Gariglio V, et al. HBV-DNA and HBcAb IgG in blood donor population. Vox Sanguinis. 2006;91:51

 None of the co-authors has any conflict of interest to declare concerning the material presented in this manuscript. Dr. Allain is an occasional lecturer for the Chiron/Novartis Corporation.

PII: S0168-8278(08)00346-2

doi: 10.1016/j.jhep.2008.04.017

Journal of Hepatology
Volume 49, Issue 4 , Pages 537-547 , October 2008